Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
34,95 USD | +2,64% | +5,97% | +62,41% |
15/05 | Spyre Therapeutics, Inc. Kondigt wijzigingen in de Raad van Bestuur aan | CI |
13/05 | SPYRE THERAPEUTICS, INC. : Wells Fargo Securities herhaalt koopadvies | ZM |
Omzet 2024 * | 5,84 mln. 5,39 mln. | Omzet 2025 * | 4,43 mln. 4,08 mln. | Marktkapitalisatie | 1,77 mld. 1,64 mld. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -174 mln. -160 mln. | Nettowinst (verlies) 2025 * | -193 mln. -178 mln. | EV/omzet 2024 * | 195 x |
Nettoliquiditeiten 2024 * | 638 mln. 588 mln. | Nettoliquiditeiten 2025 * | 333 mln. 307 mln. | EV/omzet 2025 * | 326 x |
K/w-verhouding 2024 * |
-8,35
x | K/w-verhouding 2025 * |
-9,76
x | Werknemers | 30 |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 70,36% |
Recentste transcriptie over Spyre Therapeutics, Inc.
1 dag | +2,64% | ||
1 week | +5,97% | ||
1 maand | +3,19% | ||
3 maanden | +16,89% | ||
6 maanden | +78,50% | ||
Lopend jaar | +62,41% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Cameron Turtle
CEO | Chief Executive Officer | 34 | 22-06-23 |
Scott Burrows
DFI | Director of Finance/CFO | 47 | 01-09-23 |
Brian Connolly
CTO | Chief Tech/Sci/R&D Officer | - | 27/11 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Tomas Kiselak
BRD | Director/Board Member | 37 | 22-06-23 |
Jeffrey Albers
BRD | Director/Board Member | 52 | 27/11 |
Peter Harwin
BRD | Director/Board Member | 38 | 22-06-23 |
Datum | Koers | Variatie | Volume |
---|---|---|---|
31-05-24 | 34,95 | +2,64% | 393 781 |
30-05-24 | 34,05 | +6,21% | 231 487 |
29-05-24 | 32,06 | -3,11% | 261 996 |
28-05-24 | 33,09 | +0,33% | 295 562 |
24-05-24 | 32,98 | +0,92% | 323 928 |
uitgestelde koers Nasdaq, 31 mei 2024 om 22:00 uur
Meer koersenHerzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
+62,41% | 1,77 mld. | |
+11,60% | 106 mld. | |
-4,68% | 24,28 mld. | |
-0,82% | 21,96 mld. | |
-10,12% | 18,16 mld. | |
-42,12% | 16,37 mld. | |
-17,47% | 15,56 mld. | |
+2,77% | 13,63 mld. | |
+34,58% | 12,27 mld. | |
+77,64% | 8,87 mld. |